[Skip to Navigation]
Sign In
Figure 1. 
Functional stages (modified from the Scale of Severity of Illness designed by Hirayama et al).

Functional stages (modified from the Scale of Severity of Illness designed by Hirayama et al8).

Figure 2. 
Autonomic Symptoms Questionnaire (modified from Low).

Autonomic Symptoms Questionnaire (modified from Low13).

Figure 3. 
R-R interval variation in a healthy subject (A) and patient F-2 (B). Reduced R-R interval variation is seen in patient F-2 during deep breathing (upper trace) and the Valsalva maneuver (lower trace). The horizontal bar marked as “VM” represents a Valsalva maneuver performed for 15 seconds. bpm Indicates beats per minute.

R-R interval variation in a healthy subject (A) and patient F-2 (B). Reduced R-R interval variation is seen in patient F-2 during deep breathing (upper trace) and the Valsalva maneuver (lower trace). The horizontal bar marked as “VM” represents a Valsalva maneuver performed for 15 seconds. bpm Indicates beats per minute.

Figure 4. 
Scatterplots showing R-R interval variation. The expiratory-inspiratory (E/I) ratio (A) (mean ± SD, 1.18 ± 0.1 compared with 1.36 ± 0.1) and the Valsalva ratio (B) (mean ± SD, 1.38 ± 0.16 compared with 1.62 ± 0.29) were significantly reduced in patients with Machado-Joseph disease (MJD). The horizontal bars represent mean values. * indicates P<.01; **, P<.05.

Scatterplots showing R-R interval variation. The expiratory-inspiratory (E/I) ratio (A) (mean ± SD, 1.18 ± 0.1 compared with 1.36 ± 0.1) and the Valsalva ratio (B) (mean ± SD, 1.38 ± 0.16 compared with 1.62 ± 0.29) were significantly reduced in patients with Machado-Joseph disease (MJD). The horizontal bars represent mean values. * indicates P<.01; **, P<.05.

Figure 5. 
Electrical stimulation (upper traces) and magnetic stimulation (lower traces) in a healthy subject (A), a patient with prolonged latencies (patient G-1) (B), and a patient with absent response (patient A-1) (C).

Electrical stimulation (upper traces) and magnetic stimulation (lower traces) in a healthy subject (A), a patient with prolonged latencies (patient G-1) (B), and a patient with absent response (patient A-1) (C).

Figure 6. 
Scatterplots for electrical stimulation (A and B) and magnetic stimulation (C and D). The latencies of both tests were prolonged in patients with Machado-Joseph disease (MJD) (A and C). The amplitude showed no significant differences between healthy subjects and patients with MJD (B and D). The horizontal bars indicate mean values. The asterisk indicates P<.01.

Scatterplots for electrical stimulation (A and B) and magnetic stimulation (C and D). The latencies of both tests were prolonged in patients with Machado-Joseph disease (MJD) (A and C). The amplitude showed no significant differences between healthy subjects and patients with MJD (B and D). The horizontal bars indicate mean values. The asterisk indicates P<.01.

Table 1. Clinical Features of 15 Patients With Machado-Joseph Disease
Clinical Features of 15 Patients With Machado-Joseph Disease
Table 2. Clinical Evaluation and Electrophysiological Findings in the Studied Subjects*
Clinical Evaluation and Electrophysiological Findings in the Studied Subjects*
Table 3. Relationship Between Clinical Factors and Autonomic Dysfunction Calculated From Individual Reports*
Relationship Between Clinical Factors and Autonomic Dysfunction Calculated From Individual Reports*
1.
Kawaguchi  YOkamoto  TTaniwaki  M  et al.  CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1.  Nat Genet 1994;8221- 228PubMedGoogle ScholarCrossref
2.
Rosenberg  RN Machado-Joseph disease: an autosomal dominant motor system degeneration.  Mov Disord 1992;7193- 203PubMedGoogle ScholarCrossref
3.
Sequeiros  JCoutinho  P Epidemiology and clinical aspects of Machado-Joseph disease.  Adv Neurol 1993;61139- 153PubMedGoogle Scholar
4.
Jardim  LBPereira  MLSilveira  IFerro  ASequeiros  JGiugliani  R Neurologic findings in Machado-Joseph disease: relation with disease duration, subtypes, and (CAG)n.  Arch Neurol 2001;58899- 904PubMedGoogle ScholarCrossref
5.
Schols  LAmoiridis  GEpplen  JTLangkafel  MPrzuntek  HRiess  O Relations between genotype and phenotype in German patients with the Machado-Joseph disease mutation.  J Neurol Neurosurg Psychiatry 1996;61466- 470PubMedGoogle ScholarCrossref
6.
Watanabe  MAbe  KAoki  M  et al.  Analysis of CAG trinucleotide expansion associated with Machado-Joseph disease.  J Neurol Sci 1996;136101- 107PubMedGoogle ScholarCrossref
7.
Soong  BCheng  CHLiu  RSShan  DE Machado-Joseph disease: clinical, molecular, and metabolic characterization in Chinese kindreds.  Ann Neurol 1997;41446- 452PubMedGoogle ScholarCrossref
8.
Hirayama  KTakayanagi  TNakamura  R  et al.  Spinocerebellar degenerations in Japan: a nationwide epidemiological and clinical study.  Acta Neurol Scand Suppl 1994;1531- 22PubMedGoogle ScholarCrossref
9.
Wenning  GKScherfler  CGranata  R  et al.  Time course of symptomatic orthostatic hypotension and urinary incontinence in patients with postmortem confirmed parkinsonian syndromes: a clinicopathological study.  J Neurol Neurosurg Psychiatry 1999;67620- 623PubMedGoogle ScholarCrossref
10.
Kazuta  THayashi  MShimizu  TIwasaki  ANakamura  SHirai  S Autonomic dysfunction in Machado-Joseph disease assessed by iodine123-labeled metaiodobenzylguanidine myocardial scintigraphy.  Clin Auton Res 2000;10111- 115PubMedGoogle ScholarCrossref
11.
Sakajiri  KMakifuchi  TFukuhara  NNakajima  T Quantitative study of intermediolateral column cell counts in Machado-Joseph disease.  J Neurol Sci 1996;144156- 159PubMedGoogle ScholarCrossref
12.
Yamada  MHayashi  STsuji  STakahashi  H Involvement of the cerebral cortex and autonomic ganglia in Machado-Joseph disease.  Acta Neuropathol (Berl) 2001;101140- 144PubMedGoogle Scholar
13.
Low  PA Clinical Autonomic Disorders: Evaluation and Management.  Boston, Mass: Little, Brown & Co; 1993
14.
Ravits  JM AAEM minimonograph #48: autonomic nervous system testing.  Muscle Nerve 1997;20919- 937PubMedGoogle ScholarCrossref
15.
Matsunaga  KUozumi  TTsuji  SMurai  Y Sympathetic skin responses evoked by magnetic stimulation of the neck.  J Neurol Sci 1995;128188- 194PubMedGoogle ScholarCrossref
16.
Durr  AStevanin  GCancel  G  et al.  Spinocerebellar ataxia 3 and Machado-Joseph disease: clinical, molecular, and neuropathological features.  Ann Neurol 1996;39490- 499PubMedGoogle ScholarCrossref
17.
Yokota  THayashi  MTanabe  HTsukagoshi  H Sympathetic skin response in patients with cerebellar degeneration.  Arch Neurol 1993;50422- 427PubMedGoogle ScholarCrossref
18.
Den Heijer  JCBollen  WLEMReulen  JPH  et al.  Autonomic nervous function in Huntington's disease.  Arch Neurol 1988;45309- 312PubMedGoogle ScholarCrossref
19.
Sharma  KRRomano  JGAyyar  DRRotta  FTFacca  ASanchez-Ramos  J Sympathetic skin response and heart rate variability in patients with Huntington disease.  Arch Neurol 1999;561248- 1252PubMedGoogle ScholarCrossref
20.
Schols  LAmoiridis  GBornke  CPrzuntek  H Sympathetic skin response in cerebellar ataxias [abstract].  Electroencephalogr Clin Neurophysiol 1997;10253Google ScholarCrossref
Original Contribution
April 2005

Autonomic Dysfunction in Machado-Joseph Disease

Author Affiliations

Author Affiliations: First Department of Neurology (Drs Yeh, Lu, Wu, Han, and Chen) and Human Molecular Genetic Laboratory (Dr Chou), Chang Gung Memorial Hospital, Taipei, Taiwan; Department of Neurology, Da Chien General Hospital, Miaoli, Taiwan (Dr Chong).

Arch Neurol. 2005;62(4):630-636. doi:10.1001/archneur.62.4.630
Abstract

Objective  Machado-Joseph disease is an autosomal dominant spinocerebellar ataxia with expanded trinucleotide repeats. Although autonomic nervous system degeneration was documented in postmortem reports, the autonomic dysfunction in patients with Machado-Joseph disease, either in clinical analysis or electrophysiological investigations, has not yet been studied in detail.

Methods  Fifteen patients with genetically confirmed Machado-Joseph disease and 34 healthy subjects were studied. The study design included a detailed questionnaire, R-R interval variation on deep breathing or Valsalva maneuver, and sympathetic skin response evoked by electrical stimulation of the median nerve or magnetic stimulation of the neck.

Results  Sixty-seven percent of patients had at least 3 symptoms involving different aspects of autonomic functions. Voiding problems and thermoregulatory disturbance were the most common symptoms. Ten (71%) of 14 patients had abnormal R-R interval variation with a significant reduction of the mean ratio. Prolonged latency or absence of sympathetic skin response to electrical stimulation was identified in 73% of patients and to magnetic stimulation, in 53%. R-R interval variation and sympathetic skin response showed good correlation with the functional stage. Electrical stimulation revealed the highest sensitivity, specificity, and positive predictive value compared with other tests.

Conclusion  The present investigation documents that autonomic dysfunction is not uncommon in patients with Machado-Joseph disease and might be related to the clinical progression.

Machado-Joseph disease (MJD) belongs to a group of genetic diseases with expanded trinucleotide repeats and is a neurodegenerative disease affecting multiple systems with heterogeneous phenotypic manifestations.1-4 Although the number of trinucleotide repeats inversely correlates with the age at onset,5-7 the relationship between genotype and clinical manifestations, particularly autonomic functions, is unclear.

In patients with neurodegenerative diseases, such as olivopontocerebellar degeneration or multiple system atrophy, various degrees of autonomic dysfunction are frequently observed and sometimes account for the dominant manifestations.8,9 Following this logic, autonomic dysfunction also should be evident in patients with MJD. Clinical analysis and neuropathological reports in the literature indicate that autonomic nervous system involvement might be important and overlooked in MJD.3,8,10-12

We examined autonomic function in 15 patients with MJD, using a detailed questionnaire and 2 electrophysiological tests. R-R interval variation (RRIV) and sympathetic skin response (SSR) have been reported to be reliable, objective, and quantitative methods in assessing the parasympathetic and sympathetic autonomic functions.13-15 In our investigation, we addressed the following issues: (1) Is autonomic dysfunction common in patients with MJD? (2) Does the frequency and severity of autonomic involvement in patients correlate with clinical features such as disease severity, disease duration, age at onset, and number of CAG repeats? and (3) Are SSR and RRIV sensitive methods for early detection of autonomic dysfunction in patients with MJD?

Methods
Subjects

Fifteen patients with MJD from 8 unrelated families (A-H) were included in this study. Diagnosis of MJD was confirmed by screening the expanded trinucleotide repeats on the MJD1 gene using standard methods.1Table 1> summarizes the clinical features of the 15 patients. Functional stage was scored by the modified scale designed by Hirayama et al8 (Figure 1). Clinical assessment of various autonomic symptoms was conducted using a detailed questionnaire modified from Low13 (Figure 2).

For electrophysiological studies of autonomic function, 34 healthy subjects were recruited as controls (15 men and 19 women; mean ± SD age, 39.7 ± 14.3 years [range, 20-73 years]). Patients and controls had no clinical evidence of neuropathies or carpal tunnel syndrome by nerve conduction studies, and none were taking sedative or cardiovascular drugs that might affect autonomic function. All subjects provided informed consent for the procedures, which were approved by the hospital ethics committee.

R-r interval variation

The subjects were relaxed, sitting comfortably, and had empty bladders. The study protocol was followed using a well-established, standard procedure.13,14 The responses were amplified using an electromyographic machine (Viking IV; Nicolet, Madison, Wis) with the bandpass between 1 and 30 Hz and with 2 minutes of analysis time. The subject was instructed to breathe deeply at a rate of 6 respiratory cycles per minute. The expiratory-inspiratory ratio on deep breathing was calculated by dividing the maximal R-R interval during expiration by the minimal R-R interval during inspiration. Heart rate variation on Valsalva maneuver was assessed by instructing subjects to take a full breath in and then blow into the mouthpiece connected to a manometer to the mark when 40 mm Hg had been attained for 15 seconds. The Valsalva ratio was determined by dividing the maximal R-R interval by the minimal R-R interval. The test excluded subjects with arrhythmia.

Sympathetic skin responses

This investigation used 2 methods for activating the sympathetic nervous system: electrical stimulation of the contralateral median nerve at the wrist13,14 and magnetic stimulation applied on the neck.15 The SSR recordings were performed according to well-established, standard procedure with the patient sitting comfortably in the room maintained at 22°C.13-15 Responses were amplified with the bandpass between 0.2 and 3000 Hz, using an analysis time of 10 seconds. At least 5 responses were obtained and stored for analysis. Hand and finger skin temperatures were maintained at 32°C to 34°C. Electrical stimulation of the median nerve was delivered with constant current square pulses of 5 to 15 mA in intensity for 0.2 millisecond and was administered at random intervals of longer than 1 minute to avoid habituation. Magnetic stimulation, which was generated by Magstim model 200 circular coil stimulator (Magstim, Whitland, Dyfed, Wales), was applied over the seventh cervical spinous process for 1 millisecond and was given at intervals that normally exceeded 1 minute. The optimal responses determined by the waveform with the largest amplitude were analyzed. Absence of waveform or prolonged latency were considered abnormal results.

Statistical analysis

Statistical analyses were performed using SPSS 10.0 for Windows (SPSS Inc, Chicago, Ill). All data were expressed as mean ± SD. The Mann-Whitney U test was used to compare electrophysiological data values between patients and control subjects. Sensitivity, specificity, and positive predictive value of each electrophysiological test were determined by the χ2 method. The relationship between various parameters was assessed using Pearson correlation or Spearman rank correlation according to the type of data. A P value lower than .05 was considered significant.

Results
Autonomic function evaluation

Table 2> lists the most representative autonomic symptoms in the 15 patients with MJD. The most prevalent problems were cold intolerance and nocturia. Seven patients experienced orthostatic dizziness, but none of them ever had syncope. Orthostatic hypotension was noted in patient D-1 (age at onset, 46 years; disease duration, 6 years; CAG length, 72) and patient F-1 (age at onset, 42 years; disease duration, 5 years; CAG length, 78).

The same questionnaire was also given to 47 healthy controls and 21 patients with early-stage Parkinson disease. The frequencies of each autonomic symptom are listed in Table 2>. The majority of symptoms occurred in fewer than 5% of healthy subjects except cold intolerance, dry mouth, and dry eye.

R-r interval variation

The RRIV results were abnormal in more than half of 14 patients without arrhythmia, based on age-specific normal values (Table 2>). Figure 3 illustrates the traces of RRIV obtained from a healthy subject and a patient with MJD. Figure 4 shows scatterplots to demonstrate the significance. The sensitivity, specificity, and positive predictive value of RRIV under deep breathing were 42.9%, 93.8%, and 85.7%, respectively. Those for Valsalva maneuver were 64.3%, 66.7%, and 64.3%.

Sympathetic skin responses

The results of electrical stimulation were abnormal in 11 (73.3%) of 15 patients and of magnetic stimulation, in 8 (53.3%) (Table 2>). Figure 5 displays the representative traces of normal SSR results, prolonged latency, and absence of waveform. Four patients displayed absence of waveform for both electrical stimulation and magnetic stimulation. Mean ± SD latencies of electrical stimulation were considerably prolonged in 11 patients with MJD (right hand, 1628.2 ± 157.3 milliseconds compared with 1404 ± 87.5 milliseconds; P<.001; left hand, 1634.6 ± 219.2 milliseconds compared with 1408.5 ± 104.1 milliseconds; P<.001) (Figure 6). Similar prolonged latencies were noted in magnetic stimulation (right hand, 1626.4 ± 240.7 milliseconds compared with 1407.7 ± 141.7 milliseconds; P = .005; left hand, 1560 ± 224.6 milliseconds compared with 1393 ± 147.8 milliseconds; P = .015).Mean amplitudes of electrical stimulation or magnetic stimulation did not differ between the control and patient groups (Figure 6). There were no differences in SSR measurements between either side. For electrical stimulation, the sensitivity, specificity, and positive predictive value were 73.3%, 97.1%, and 91.7%, respectively. Those for magnetic stimulation were 53.3%, 86.7%, and 66.7%.

Relations between clinical and electrophysiological studies

Similar inverse correlation was observed between number of trinucleotide repeats and age at onset in our patients. However, no correlations were observed among autonomic symptoms, electrophysiological tests, and clinical factors such as disease severity, disease duration, age at onset, and number of CAG repeats.

The results of deep breathing correlated with functional stage (P = .04), orthostatic dizziness (P = .03), and pyramidal signs (P = .03). The results of Valsalva maneuver correlated well with nocturia (P = .04) and diarrhea (P = .03). The results of electrical stimulation correlated with functional stage (P = .002) but were inversely correlated with parkinsonian signs (P = .008) and dry mouth (P = .04). The results of magnetic stimulation also correlated closely with functional stage (P = .001) and gait ataxia (P = .008).

Comment

This study investigated autonomic functions in patients with genetically confirmed MJD from 8 unrelated families. Four major findings were obtained. First, autonomic symptoms were common in patients with MJD. Second, abnormal reduction of RRIV, suggesting parasympathetic cardiovagal dysfunction, was present in 10 (71%) of 14 patients. Third, 11 (73%) of 15 patients had absence or prolonged latency of SSR, evoked either by electrical stimulation or magnetic stimulation, suggesting sympathetic sudomotor dysfunction. Fourth, both RRIV and SSR correlated closely with functional stage, but correlations among the different clinical features varied.

Ten patients (66%) had at least 3 diverse symptoms involving different aspects of autonomic functions (Table 2>). In the literature, the rate of autonomic dysfunction in MJD varied from 5% to 55%.3,5-8,10 Although it is unclear why the incidence of autonomic perturbation is higher in the present series, most reports on this issue did not show detailed clinical manifestations. Autonomic dysfunction in MJD may sometimes be overlooked owing to marked motor disturbances. Accordingly, increased awareness of these symptoms is important in treating patients with MJD.

Intriguingly, the rate of autonomic dysfunction in MJD appeared higher in Asian individuals than in white individuals.3,5,6,8,10,16 The most frequent manifestation was urinary disturbance. Sequeiros and Coutinho3 reported difficulty in sphincter control in 5.8% of 143 Portuguese patients. The nationwide epidemiological survey in Japan reported voiding dysfunction in 31.3% of 66 patients.8 Clinical analysis of autonomic functions in Chinese patients is still not available. Soong et al7 reported autonomic dysfunction in 6 of 25 patients but did not describe their symptoms. In our series, 53% of patients also had urinary disturbance of nocturia and/or urine incontinence. Although this phenomenon was in concordance with the Japanese groups, the racial difference of distinct autonomic manifestation in MJD might need further elucidation.

It is useful and interesting to identify factors that can modify the variable expression in clinical symptoms and demographic data in a multisystem degenerative disease. Durr et al,16 as well as Hirayama et al,8 reported that the disease duration seemed to be a factor that could partially explain the heterogeneity of ataxia, dysarthria, dysphagia, fasciculation, pyramidal syndrome, ophthalmoplegia, and possibly the autonomic dysfunction. However, these 2 reports did not include comprehensive clinical investigation or correlative statistical analysis. Table 3> reassesses the relationship between clinical factors and autonomic dysfunction by reanalyzing the individual data from another 4 studies.5-7,10 Including ours, these 5 studies showed no differences in the repeat length, age at onset, age at examination, and disease duration between the presence and absence of autonomic dysfunction. A larger sample size is required to search for possible factors influencing the nature and progression of autonomic dysfunction.

The RRIV is a simple and sensitive method for evaluating parasympathetic function in different disease entities.13,14 To our knowledge, the only report of RRIV in MJD described normal results in 6 patients.17 On the contrary, we documented that more than 40% of patients had abnormal RRIV results (43% on deep breathing and 64% on Valsalva maneuver). The reason for this discrepancy was unclear; however, the results of RRIV in Huntington disease also had the same discrepancy.18,19

Sympathetic skin response is used to assess the integrity of sympathetic sudomotor function.13-15 More than half of our patients had abnormal SSR results. In contrast to the RRIV, the findings of this investigation were consistent with previous works.10,17,20 We found that the abnormal frequency was higher in electrical stimulation (73%) than magnetic stimulation (53%). The evoked SSR after magnetic stimulation is presumed mainly from direct activation of postganglionic sympathetic neurons with little influence from sensory afferent fibers.15 The present findings suggest that the afferent pathway and central modulation of sudomotor function might be more frequently affected than the efferent pathway and that electrical stimulation was more sensitive than magnetic stimulation in detecting sudomotor dysfunction in patients with MJD.

In this series, correlation between electrophysiological tests and autonomic symptoms was variable and weak. Although such findings were also reported by other groups,20 a serial follow-up study with a larger sample size is warranted to identify the effect of these autonomic tests in predicting clinical outcome. In this series, however, we found good correlation of such tests and clinical progression and documented the validity of RRIV and SSR in patients with MJD. Electrical stimulation revealed the highest sensitivity, specificity, and positive predictive value. The RRIV of deep breathing showed a higher predictive value than the Valsalva maneuver for detecting parasympathetic dysfunction in MJD.

In conclusion, our investigation found that autonomic dysfunctions were not uncommon in patients with MJD, using either clinical or electrophysiological studies. The high rate of abnormalities in RRIV and SSR indicated that both the parasympathetic and sympathetic nervous systems were affected in MJD and were correlated with the progression of disease.

Back to top
Article Information

Correspondence: Rou-Shayn Chen, MD, Movement Disorders Unit, First Department of Neurology, Chang Gung Memorial Hospital 199, Tung-Hwa North Road, Taipei 10591, Taiwan (cerebrum@ms13.hinet.net).

Accepted for Publication: July 27, 2004.

Author Contributions:Study concept and design: Yeh, Lu, and Chen. Acquisition of data: Yeh, Chong, Han, and Chen. Analysis and interpretation of data: Yeh, Chou, Wu, and Chen. Drafting of the manuscript: Yeh, Lu, Chou, Chong, Wu, Han, and Chen. Critical revision of the manuscript for important intellectual content: Yeh and Chen. Statistical analysis: Yeh. Obtained funding: Lu and Chen. Administrative, technical, and material support: Yeh, Lu, Chou, and Chen. Study supervision: Lu and Chen.

Funding/Support: This study was supported by grant NSC 87-2314-B-182A-022 from the National Science Council, Taipei, Taiwan, and grant CMRP 857 from the Chang Gung Memorial Hospital research foundation, Taipei.

Acknowledgment: We would like to thank the National Science Council and Chang Gung Memorial Hospital research foundation.

References
1.
Kawaguchi  YOkamoto  TTaniwaki  M  et al.  CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1.  Nat Genet 1994;8221- 228PubMedGoogle ScholarCrossref
2.
Rosenberg  RN Machado-Joseph disease: an autosomal dominant motor system degeneration.  Mov Disord 1992;7193- 203PubMedGoogle ScholarCrossref
3.
Sequeiros  JCoutinho  P Epidemiology and clinical aspects of Machado-Joseph disease.  Adv Neurol 1993;61139- 153PubMedGoogle Scholar
4.
Jardim  LBPereira  MLSilveira  IFerro  ASequeiros  JGiugliani  R Neurologic findings in Machado-Joseph disease: relation with disease duration, subtypes, and (CAG)n.  Arch Neurol 2001;58899- 904PubMedGoogle ScholarCrossref
5.
Schols  LAmoiridis  GEpplen  JTLangkafel  MPrzuntek  HRiess  O Relations between genotype and phenotype in German patients with the Machado-Joseph disease mutation.  J Neurol Neurosurg Psychiatry 1996;61466- 470PubMedGoogle ScholarCrossref
6.
Watanabe  MAbe  KAoki  M  et al.  Analysis of CAG trinucleotide expansion associated with Machado-Joseph disease.  J Neurol Sci 1996;136101- 107PubMedGoogle ScholarCrossref
7.
Soong  BCheng  CHLiu  RSShan  DE Machado-Joseph disease: clinical, molecular, and metabolic characterization in Chinese kindreds.  Ann Neurol 1997;41446- 452PubMedGoogle ScholarCrossref
8.
Hirayama  KTakayanagi  TNakamura  R  et al.  Spinocerebellar degenerations in Japan: a nationwide epidemiological and clinical study.  Acta Neurol Scand Suppl 1994;1531- 22PubMedGoogle ScholarCrossref
9.
Wenning  GKScherfler  CGranata  R  et al.  Time course of symptomatic orthostatic hypotension and urinary incontinence in patients with postmortem confirmed parkinsonian syndromes: a clinicopathological study.  J Neurol Neurosurg Psychiatry 1999;67620- 623PubMedGoogle ScholarCrossref
10.
Kazuta  THayashi  MShimizu  TIwasaki  ANakamura  SHirai  S Autonomic dysfunction in Machado-Joseph disease assessed by iodine123-labeled metaiodobenzylguanidine myocardial scintigraphy.  Clin Auton Res 2000;10111- 115PubMedGoogle ScholarCrossref
11.
Sakajiri  KMakifuchi  TFukuhara  NNakajima  T Quantitative study of intermediolateral column cell counts in Machado-Joseph disease.  J Neurol Sci 1996;144156- 159PubMedGoogle ScholarCrossref
12.
Yamada  MHayashi  STsuji  STakahashi  H Involvement of the cerebral cortex and autonomic ganglia in Machado-Joseph disease.  Acta Neuropathol (Berl) 2001;101140- 144PubMedGoogle Scholar
13.
Low  PA Clinical Autonomic Disorders: Evaluation and Management.  Boston, Mass: Little, Brown & Co; 1993
14.
Ravits  JM AAEM minimonograph #48: autonomic nervous system testing.  Muscle Nerve 1997;20919- 937PubMedGoogle ScholarCrossref
15.
Matsunaga  KUozumi  TTsuji  SMurai  Y Sympathetic skin responses evoked by magnetic stimulation of the neck.  J Neurol Sci 1995;128188- 194PubMedGoogle ScholarCrossref
16.
Durr  AStevanin  GCancel  G  et al.  Spinocerebellar ataxia 3 and Machado-Joseph disease: clinical, molecular, and neuropathological features.  Ann Neurol 1996;39490- 499PubMedGoogle ScholarCrossref
17.
Yokota  THayashi  MTanabe  HTsukagoshi  H Sympathetic skin response in patients with cerebellar degeneration.  Arch Neurol 1993;50422- 427PubMedGoogle ScholarCrossref
18.
Den Heijer  JCBollen  WLEMReulen  JPH  et al.  Autonomic nervous function in Huntington's disease.  Arch Neurol 1988;45309- 312PubMedGoogle ScholarCrossref
19.
Sharma  KRRomano  JGAyyar  DRRotta  FTFacca  ASanchez-Ramos  J Sympathetic skin response and heart rate variability in patients with Huntington disease.  Arch Neurol 1999;561248- 1252PubMedGoogle ScholarCrossref
20.
Schols  LAmoiridis  GBornke  CPrzuntek  H Sympathetic skin response in cerebellar ataxias [abstract].  Electroencephalogr Clin Neurophysiol 1997;10253Google ScholarCrossref
×